![Robert C. Getts](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert C. Getts
Direttore/Membro del Consiglio presso Genisphere LLC
Profilo
Robert C.
Getts is currently a Director at Genisphere LLC.
Previously, he worked as a Principal at Philadelphia College of Osteopathic Medicine.
He holds a doctorate degree from Lehigh University and undergraduate and graduate degrees from the University of Scranton.
Posizioni attive di Robert C. Getts
Società | Posizione | Inizio |
---|---|---|
Genisphere LLC
![]() Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Robert C. Getts
Società | Posizione | Fine |
---|---|---|
Philadelphia College of Osteopathic Medicine | Corporate Officer/Principal | - |
Formazione di Robert C. Getts
University of Scranton | Graduate Degree |
Lehigh University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Genisphere LLC
![]() Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Electronic Technology |
- Borsa valori
- Insiders
- Robert C. Getts